Advancing the Science

Mayo Clinic Medical Science Blog

Items Tagged ‘rivaroxaban’

June 19th, 2017

1 in 6 taking blood-thinning drugs may not be getting right dose, research shows

By Adam Harringa harringaadam

A growing number of Americans are expected to develop atrial fibrillation, a common heart condition characterized by an irregular and rapid heart rate. But almost 1 in 6 of the millions of Americans on new blood-thinning medications for a-fib may not be getting the right dose, Mayo Clinic research finds.

View full entry

Tags: anticoagulant, apixaban, atrial fibrillation, blood-thinner, dabigatran, Dr. Peter Noseworthy, Dr. Xiaoxi Yao, Kern Center, kidney disease, Mayo Clinic research, medical research, OptumLabs

May 3rd, 2016


By Elizabeth Zimmermann Young elizabethzimmermann

Determining which drug works better for which patients “Our findings definitely point toward important age-related risk that merits consideration when doctors are making treatment recommendations,” says lead author Neena S. Abraham, M.D. To the average TV viewer, it may seem like new drugs flood the marketplace daily.However, from the 1950s until just recently, warfarin was […]

View full entry

Tags: anticoagulant, atrial fibrillation, Center for the Science of Health Care Delivery, dabigatran, Kern Center, medical research, Neena Abraham, rivaroxaban, warfarin

May 29th, 2015

Precision Medicine Using Big Data

By Elizabeth Zimmermann Young elizabethzimmermann

One of our goals at Mayo Clinic is to improve the way patients experience health care. We established the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery to investigate ways to improve across the continuum of health care delivery. In the center, we look at systems engineering, […]

View full entry

Tags: anticoagulant, Big Data, BMJ, dabigatran, health care delivery, individualized Medicine, Kern Center, Neena Abraham, Optum Labs, Precision Medicine, rivaroxaban, Science of health care delivery

Contact Us · Privacy Policy